Alberto A Gabizon (Alberto Gabizon)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Top Venues

Molecular cancer therapeutics

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Antonia Charalambous, Fotios Mpekris, Myrofora Panagi, Chrysovalantis Voutouri, Christina Michael, Alberto A Gabizon, Triantafyllos Stylianopoulos
Tumor microenvironment reprogramming improves nanomedicine-based chemo-immunotherapy in sarcomas. Molecular cancer therapeutics (2024)
Md Rakibul Islam, Jalpa Patel, Patricia Ines Back, Hilary Shmeeda, Raja Reddy Kallem, Claire Shudde, Maciej Markiewski, William C Putnam, Alberto A Gabizon, Ninh M La-Beck
Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model. Biomolecules 13 (9) (2023)
Shira Dorot, James Tankel, Victoria Doviner, Hilary Shmeeda, Yasmine Amitay, Patricia Ohana, Amir Dagan, Menachem Ben-Haim, Petachia Reissman, Alberto A Gabizon
Ex-vivo activation of a liposomal prodrug of mitomycin C by human tumors. Cancer chemotherapy and pharmacology 90 (2) (2022)
Alberto A Gabizon, Esther Tahover, Talia Golan, Ravit Geva, Ruth Perets, Yasmine Amitay, Hilary Shmeeda, Patricia Ohana
Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patients. Investigational new drugs 38 (5) (2020)
Alberto A Gabizon, Janos Szebeni
Complement Activation: A Potential Threat on the Safety of Poly(ethylene glycol)-Coated Nanomedicines. ACS nano 14 (7) (2020)